Shares of Phibro Animal Health Corporation (PAHC) surged over 5% in extended trading on Wednesday, following the company's impressive fiscal second-quarter results and an upbeat full-year revenue forecast.
For the quarter ended December 31, 2024, Phibro reported adjusted earnings per share of $0.54, comfortably beating analysts' expectations of $0.42. The animal health and mineral nutrition company's revenue grew nearly 24% year-over-year to $309.3 million, also exceeding consensus estimates of $303.84 million.
Notably, Phibro raised its fiscal 2025 revenue guidance to a range of $1.25 billion to $1.30 billion, compared to analysts' average projection of $1.32 billion. The company cited strong demand across its animal health and nutrition businesses for the upbeat outlook.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。